Alimera Sciences Inc


Here’s Why Cowen Upgraded Alimera Sciences Inc (ALIM) Shares

With near-term financing overhang removed and more confident in Iluvien’s sales growth, Cowen analyst Boris Peaker upgrades shares of Alimera Sciences Inc (NASDAQ:ALIM) from Market …

Friday’s Biotech Roundup: Merrimack Pharmaceuticals Inc (MACK), Juno Therapeutics Inc (JUNO), Alimera Sciences Inc (ALIM), Relypsa Inc (RLYP)

Merrimack Pharmaceuticals Inc Merrimack Pharmaceuticals Inc (NASDAQ:MACK) shares closed down over 6% Friday, after the cancer drug maker reported second-quarter results, with net Onivyde sales …

Cowen Remains Cautious on Alimera Sciences Inc (ALIM) Following 2Q:16 Results

In a research report released Tuesday, Cowen analyst Boris Peaker reiterated a Market Perform rating on shares of Alimera Sciences Inc (NASDAQ:ALIM), with a …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts